Amy Heaps

530 total citations
9 papers, 46 citations indexed

About

Amy Heaps is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Amy Heaps has authored 9 papers receiving a total of 46 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Virology and 3 papers in Molecular Biology. Recurrent topics in Amy Heaps's work include SARS-CoV-2 and COVID-19 Research (5 papers), HIV/AIDS Research and Interventions (4 papers) and HIV Research and Treatment (4 papers). Amy Heaps is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), HIV/AIDS Research and Interventions (4 papers) and HIV Research and Treatment (4 papers). Amy Heaps collaborates with scholars based in United States, South Africa and Zimbabwe. Amy Heaps's co-authors include Urvi M. Parikh, Edward Livant, Natasha Samsunder, Jeanne Marrazzo, Zvavahera M. Chirenje, Ravindre Panchia, John W. Mellors, Sufia Dadabhai, Colin O’Rourke and Gita Ramjee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Amy Heaps

6 papers receiving 45 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Heaps United States 4 38 33 11 4 3 9 46
Nolwenn Hall France 5 53 1.4× 36 1.1× 19 1.7× 4 1.0× 6 56
Alain Goudeau France 3 29 0.8× 29 0.9× 14 1.3× 6 1.5× 2 0.7× 5 49
Ighor Arantes Brazil 5 46 1.2× 25 0.8× 10 0.9× 6 1.5× 3 1.0× 15 53
Andrew Phillips United Kingdom 5 62 1.6× 50 1.5× 14 1.3× 4 1.0× 7 68
Genesis May J. Samonte Philippines 4 35 0.9× 22 0.7× 10 0.9× 5 1.3× 8 38
Olina Ngwenya South Africa 4 59 1.6× 23 0.7× 18 1.6× 4 1.0× 2 0.7× 5 65
Concetta Vinci Italy 5 50 1.3× 42 1.3× 8 0.7× 3 1.0× 9 69
Hermann Somlaré Burkina Faso 4 55 1.4× 51 1.5× 11 1.0× 2 0.5× 5 62
S.H. Lowe Netherlands 4 25 0.7× 16 0.5× 5 0.5× 6 1.5× 1 0.3× 4 37
Josphat Kosgei United States 3 55 1.4× 44 1.3× 22 2.0× 2 0.5× 1 0.3× 9 64

Countries citing papers authored by Amy Heaps

Since Specialization
Citations

This map shows the geographic impact of Amy Heaps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Heaps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Heaps more than expected).

Fields of papers citing papers by Amy Heaps

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Heaps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Heaps. The network helps show where Amy Heaps may publish in the future.

Co-authorship network of co-authors of Amy Heaps

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Heaps. A scholar is included among the top collaborators of Amy Heaps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Heaps. Amy Heaps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Choudhary, Manish C., Amy Heaps, Rinki Deo, et al.. (2024). Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response. SHILAP Revista de lepidopterología. 9(2). 79–93. 1 indexed citations
4.
Heaps, Amy, Michele D. Sobolewski, Jana L. Jacobs, et al.. (2023). Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer. Journal of Virological Methods. 316. 114726–114726.
5.
Parikh, Urvi M., Kerri J. Penrose, Amy Heaps, et al.. (2023). Brief Report: HIV Drug Resistance Assessment Among Women Who Seroconverted During the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 95(1). 35–41. 1 indexed citations
6.
Ramirez, Sydney I., Alba Grifoni, Daniela Weiskopf, et al.. (2022). Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses. JCI Insight. 7(24). 5 indexed citations
7.
Parikh, Urvi M., Kerri J. Penrose, Amy Heaps, et al.. (2021). HIV‐1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial. Journal of the International AIDS Society. 24(11). e25833–e25833. 7 indexed citations
8.
Riddler, Sharon A., Jennifer E. Balkus, Urvi M. Parikh, et al.. (2018). Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the Microbicide Trials Network-020 Phase III Trial of the Dapivirine Vaginal Ring. Clinical Infectious Diseases. 69(3). 523–529. 11 indexed citations
9.
Livant, Edward, Amy Heaps, Natasha Samsunder, et al.. (2017). The fourth generation Alere TM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples. Journal of Clinical Virology. 94. 15–21. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026